Gene: AXDND1
Official Full Name: axonemal dynein light chain domain containing 1provided by HGNC
Gene Summary: Predicted to be involved in manchette assembly. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27128 | AXDND1 Knockout cell line (HCT 116) | Human | AXDND1 | 1:2~1:4 | Negative | Online Inquiry |
AXDND1 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to facilitate the study of the AXDND1 gene, a critical component implicated in various cellular processes, such as apoptosis, proliferation, and differentiation. By using CRISPR/Cas9 technology to create knockout mutations, these cell lines enable researchers to elucidate the gene's function and its influence on cellular behavior in a controlled environment. The disruption of AXDND1 expression offers a powerful model for investigating the underlying mechanisms of diseases, particularly in cancer research and developmental biology.
The key function of the AXDND1 Gene Knockout Cell Lines lies in their ability to serve as an invaluable tool for functional genomics. Researchers can observe phenotypic changes, signaling pathways, and gene interactions that occur in the absence of AXDND1, thus providing insights into its role in cellular homeostasis and disease pathogenesis. Moreover, these cell lines are compatible with high-throughput screening methodologies, making them ideal for pharmacological studies and drug discovery processes.
The scientific importance of these knockout cell lines is evident in their applications in both basic research and clinical settings. By using AXDND1 knockouts, scientists can model specific diseases and screen potential therapeutic agents, ultimately contributing to the development of targeted treatments. Furthermore, these cell lines offer a reproducible and reliable platform for the validation of gene editing techniques and the study of gene function.
Key advantages of the AXDND1 Gene Knockout Cell Lines include the precision and efficiency of the CRISPR/Cas9 knockout methodology, which reduces off-target effects compared to traditional genetic manipulation techniques. Additionally, these cell lines are extensively characterized, ensuring that researchers receive consistent and high-quality performance in their experiments.
Investing in the AXDND1 Gene Knockout Cell Lines provides researchers and clinicians with a unique opportunity to deepen their understanding of gene function and disease mechanisms. By using these specialized cell lines, users can enhance their research efficiency and drive innovative discoveries in genetic and biomedical research.
Our company prides itself on its expertise in providing high-quality biological products, ensuring reliable tools for groundbreaking research. We are committed to supporting scientific advancements, enabling researchers to unlock the full potential of their studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.